A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.
Inclusion Criteria:
Exclusion Criteria:
tarryn.shaw@rmh.nhs.uk020 8661 3375
Diverse cohort of patients who have undergone genetic risk profiling and have received their results
Healthcare providers who have delivered genetic risk profiling results to patients
elizabeth.bancroft@rmh.nhs.uk02087224483
Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services
Prophylactic Prostatectomy for Prostate Cancer (PPPC)
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
An Exploration of Genetic Testing for Prostate Cancer Susceptibility
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
Understanding of Genetics by Men at Risk for Prostate Cancer
Precision Medicine in the Prostate Cancer Care Pathway
UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies